The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Antibody Phage Display: Technique and Applications
Open accessAbstract
The production of human monoclonal mAbs for research and clinical use is closely related to the development of phage display technology, initially described by Smith in 1985 and further developed by other groups (e.g., Winter, McCafferty, Lerner, Barbas). Antibody phage display (APD) is based on genetic engineering of bacteriophages (viruses that infect bacteria) and repeated rounds of antigen-guided selection and phage propagation (Barbas, 2001). This technique allows in vitro selection of mAbs of virtually any specificity, greatly facilitating recombinant production of reagents for use in research and clinical diagnostics, as well as for pharmaceuticals for therapeutic use in humans (e.g., adalimumab, the first fully human APD-derived mAb) (Lee et al., 2007). Because of a physical connection established between the antibody fragment on the outside and the genetic information encoding the displayed protein within the phage, APD also allows comprehensive studies of genetics and function of antigen-specific mAbs. These characteristics make APD a powerful tool to better understand immunological processes and human diseases that involve formation of (auto-)antibodies against defined (self-)antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire
DeKosky, B. J., Ippolito, G. C., Deschner, R. P., Lavinder, J. J., Wine, Y., Rawlings, B. M., Varadarajan, N., Giesecke, C., Dörner, T., Andrews, S. F., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2492 · Cited by 410 · cited 3×
“Combination of APD with other established high-throughput methods such as nextgeneration sequencing and/or proteomics may offer the most powerful approach for future molecular deciphering of antigenspecific serum responses in disease and health (Cheung et al., 2012; DeKosky et al., 2013; Wine et al., 2013).”
BackgroundMethod
Cited by
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
Nanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Alfaleh, M. A., Alsaab, H. O., Mahmoud, A. B., Alkayyal, A. A., Jones, M. L., Mahler, S. M., & Hashem, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01986 · Cited by 273
Di Gioacchino, A., Procyk, J., Molari, M., Schreck, J. S., Zhou, Y., Liu, Y., Monasson, R., Cocco, S., & Šulc, P. (2022) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1010561 · Cited by 45
Monoclonal Antibodies: A Prospective and Retrospective View
Sivaccumar, J., Sandomenico, A., Vitagliano, L., & Ruvo, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200219142231 · Cited by 14
Metadata
- Authors
- Hammers, C. M., & Stanley, J. R.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 134
- Issue
- 2
- Pages
- 1-5
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2058972573
- Cited by
- 212
- References
- 1
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibody Phage Display: Technique and Applications. https://app.cochat.ai/papers/10.1038/jid.2013.521
- The paper
- Hammers, C. M., & Stanley, J. R. (2014). Antibody Phage Display: Technique and Applications. Journal of Investigative Dermatology. https://doi.org/10.1038/jid.2013.521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.